AI assistant
Sending…
RxSight, Inc. — Director's Dealing 2025
Aug 4, 2025
33077_dirs_2025-08-04_67618d07-5bb8-4806-907b-b25fc3483173.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: RxSight, Inc. (RXST)
CIK: 0001111485
Period of Report: 2025-07-31
Reporting Person: COHEN RAYMOND W (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-07-31 | Common Stock | A | 35668 | — | Acquired | 35668 | Direct |
Footnotes
F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of RxSight, Inc. Common Stock.
F2: Subject to the Reporting Person's continuing service as an Outside Director (as defined in the Issuer's 2021 Equity Incentive Plan) through such applicable vesting date, one third of the RSUs subject to the award shall vest on each annual anniversary of July 31, 2025.
More from RxSight, Inc.
Regulatory Filings
2026
May 6
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Annual Report
2026
Feb 25
Regulatory Filings
2026
Feb 25
Major Shareholding Notification
2026
Feb 3
Director's Dealing
2026
Jan 30